FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075129147> ?p ?o ?g. }

• W2075129147 endingPage "414" @default.
• W2075129147 startingPage "406" @default.
• W2075129147 abstract "One hundred and ninety-seven outpatients with atypical depression [Atypical Depression Diagnostic Scale (ADDS) score=4] were randomized to 12 weeks of double-blind treatment with sertraline or moclobemide in a multicentre, parallel-group clinical trial. Patients were started on either 50 mg/day sertraline or 300 mg/day moclobemide. If the therapeutic response was not satisfactoryafter 4 weeks, the dose could be increased to either 100 mg/day sertraline or 450 mg/day moclobemide. Primary effcacy evaluations were the 29-item Hamilton Psychiatric Rating Scale for Depression (HAM-D) and the Clinical Global Impression of Improvement (CGI I) response rate (much or very much improved) at study endpoint. Secondary effcacy evaluations included the ADDS, the Hamilton Anxiety Scale (HAMA), the Leeds Sleep Scale, and the Battelle Quality of Life Battery (BQOLB). In the analysis of the 172 patient effcacy-evaluable population, there was significant baseline to endpoint improvement in all primary and secondary effcacy assessments after treatment with either sertraline or moclobemide. At the endpoint, the proportion of responders on CGI-I, was 77.5% in the sertraline group and 67.5% in the moclobemide group (p=0.052). The baseline to endpoint mean 29-item HAM-D score decreased from 35.9 to 14.5 in the sertraline group and from 36.3 to 16.1 in the moclobemide group. Sertraline also resulted in a significantly (p50.05) greater degree of improvement at the endpoint, compared with moclobemide, in the proportion of remitters on the HAMA (total score47), ADDS Category IID (Rejection Sensitivity), Leeds Sleep Factor 4 (Integrity of Behaviour Following Awakening), and on three dimensions of the BQOLB (Energy/Vitality, Social Interaction and Life Satisfaction). There were no other significant differences between treatment groups. Overall, both medications were well tolerated. In this study, both sertraline and moclobemide improved the symptoms of atypical depression." @default.
• W2075129147 created "2016-06-24" @default.
• W2075129147 creator A5011969115 @default.
• W2075129147 creator A5022694312 @default.
• W2075129147 creator A5044687532 @default.
• W2075129147 creator A5050388164 @default.
• W2075129147 creator A5057147025 @default.
• W2075129147 creator A5062259358 @default.
• W2075129147 creator A5077186056 @default.
• W2075129147 creator A5078506011 @default.
• W2075129147 creator A5088380652 @default.
• W2075129147 date "1999-07-01" @default.
• W2075129147 modified "2023-10-15" @default.
• W2075129147 title "A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression" @default.
• W2075129147 cites W117890930 @default.
• W2075129147 cites W1925684278 @default.
• W2075129147 cites W1966841478 @default.
• W2075129147 cites W1989825724 @default.
• W2075129147 cites W2002071345 @default.
• W2075129147 cites W2003059806 @default.
• W2075129147 cites W2018687722 @default.
• W2075129147 cites W2029125254 @default.
• W2075129147 cites W2042791643 @default.
• W2075129147 cites W2062711369 @default.
• W2075129147 cites W2073904123 @default.
• W2075129147 cites W2111287604 @default.
• W2075129147 cites W2127188365 @default.
• W2075129147 cites W2146268699 @default.
• W2075129147 cites W2160070901 @default.
• W2075129147 cites W66160768 @default.
• W2075129147 doi "https://doi.org/10.1177/026988119901300412" @default.
• W2075129147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10667618" @default.
• W2075129147 hasPublicationYear "1999" @default.
• W2075129147 type Work @default.
• W2075129147 sameAs 2075129147 @default.
• W2075129147 citedByCount "61" @default.
• W2075129147 countsByYear W20751291472012 @default.
• W2075129147 countsByYear W20751291472013 @default.
• W2075129147 countsByYear W20751291472014 @default.
• W2075129147 countsByYear W20751291472015 @default.
• W2075129147 countsByYear W20751291472017 @default.
• W2075129147 countsByYear W20751291472018 @default.
• W2075129147 countsByYear W20751291472019 @default.
• W2075129147 countsByYear W20751291472020 @default.
• W2075129147 countsByYear W20751291472021 @default.
• W2075129147 countsByYear W20751291472022 @default.
• W2075129147 crossrefType "journal-article" @default.
• W2075129147 hasAuthorship W2075129147A5011969115 @default.
• W2075129147 hasAuthorship W2075129147A5022694312 @default.
• W2075129147 hasAuthorship W2075129147A5044687532 @default.
• W2075129147 hasAuthorship W2075129147A5050388164 @default.
• W2075129147 hasAuthorship W2075129147A5057147025 @default.
• W2075129147 hasAuthorship W2075129147A5062259358 @default.
• W2075129147 hasAuthorship W2075129147A5077186056 @default.
• W2075129147 hasAuthorship W2075129147A5078506011 @default.
• W2075129147 hasAuthorship W2075129147A5088380652 @default.
• W2075129147 hasConcept C118552586 @default.
• W2075129147 hasConcept C126322002 @default.
• W2075129147 hasConcept C139719470 @default.
• W2075129147 hasConcept C142724271 @default.
• W2075129147 hasConcept C15744967 @default.
• W2075129147 hasConcept C162324750 @default.
• W2075129147 hasConcept C168563851 @default.
• W2075129147 hasConcept C203092338 @default.
• W2075129147 hasConcept C204787440 @default.
• W2075129147 hasConcept C27081682 @default.
• W2075129147 hasConcept C2776000289 @default.
• W2075129147 hasConcept C2776466505 @default.
• W2075129147 hasConcept C2776867660 @default.
• W2075129147 hasConcept C2777669559 @default.
• W2075129147 hasConcept C2779177272 @default.
• W2075129147 hasConcept C2780051608 @default.
• W2075129147 hasConcept C2780237459 @default.
• W2075129147 hasConcept C2780733359 @default.
• W2075129147 hasConcept C42219234 @default.
• W2075129147 hasConcept C558461103 @default.
• W2075129147 hasConcept C71924100 @default.
• W2075129147 hasConceptScore W2075129147C118552586 @default.
• W2075129147 hasConceptScore W2075129147C126322002 @default.
• W2075129147 hasConceptScore W2075129147C139719470 @default.
• W2075129147 hasConceptScore W2075129147C142724271 @default.
• W2075129147 hasConceptScore W2075129147C15744967 @default.
• W2075129147 hasConceptScore W2075129147C162324750 @default.
• W2075129147 hasConceptScore W2075129147C168563851 @default.
• W2075129147 hasConceptScore W2075129147C203092338 @default.
• W2075129147 hasConceptScore W2075129147C204787440 @default.
• W2075129147 hasConceptScore W2075129147C27081682 @default.
• W2075129147 hasConceptScore W2075129147C2776000289 @default.
• W2075129147 hasConceptScore W2075129147C2776466505 @default.
• W2075129147 hasConceptScore W2075129147C2776867660 @default.
• W2075129147 hasConceptScore W2075129147C2777669559 @default.
• W2075129147 hasConceptScore W2075129147C2779177272 @default.
• W2075129147 hasConceptScore W2075129147C2780051608 @default.
• W2075129147 hasConceptScore W2075129147C2780237459 @default.
• W2075129147 hasConceptScore W2075129147C2780733359 @default.
• W2075129147 hasConceptScore W2075129147C42219234 @default.
• W2075129147 hasConceptScore W2075129147C558461103 @default.
• W2075129147 hasConceptScore W2075129147C71924100 @default.

• next